The price of Geron Corp. (NASDAQ: GERN) closed at $2.08 in the last session, down -7.96% from day before closing price of $2.26. In other words, the price has decreased by -$0.1800 from its previous closing price. On the day, 8205452 shares were traded.
Ratios:
We take a closer look at GERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.16. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.15.
On March 28, 2023, Goldman started tracking the stock assigning a Neutral rating and target price of $3.
On October 28, 2022, Wedbush started tracking the stock assigning a Outperform rating and target price of $5.Wedbush initiated its Outperform rating on October 28, 2022, with a $5 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 24 when O’Farrell Elizabeth G. bought 6,607 shares for $2.28 per share. The transaction valued at 15,064 led to the insider holds 7,407 shares of the business.
O’Farrell Elizabeth G. bought 6,579 shares of GERN for $15,000 on Aug 24. The Director now owns 26,220 shares after completing the transaction at $2.28 per share. On May 11, another insider, LAWLIS V BRYAN, who serves as the Director of the company, sold 35,000 shares for $3.00 each. As a result, the insider received 105,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1.23B and an Enterprise Value of 979.52M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4732.52 while its Price-to-Book (P/B) ratio in mrq is 4.57. Its current Enterprise Value per Revenue stands at 4.13k whereas that against EBITDA is -5.60.
Stock Price History:
Over the past 52 weeks, GERN has reached a high of $3.73, while it has fallen to a 52-week low of $1.68. The 50-Day Moving Average of the stock is 2.0546, while the 200-Day Moving Average is calculated to be 2.4093.
Shares Statistics:
According to the various share statistics, GERN traded on average about 7.01M shares per day over the past 3-months and 8.52M shares per day over the past 10 days. A total of 544.91M shares are outstanding, with a floating share count of 447.58M. Insiders hold about 18.03% of the company’s shares, while institutions hold 55.12% stake in the company. Shares short for GERN as of Feb 15, 2024 were 43.57M with a Short Ratio of 6.22, compared to 39.79M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.02% and a Short% of Float of 8.06%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.1, while EPS last year was -$0.07. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.1 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.29 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.17, with 5 analysts recommending between -$0.01 and -$0.37.
Revenue Estimates
A total of 4 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $99.35M, while the lowest revenue estimate was $47.85M, resulting in an average revenue estimate of $64.09M. In the same quarter a year ago, actual revenue was $237k, up 26,942.20% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $320.16M in the next fiscal year. The high estimate is $378.5M and the low estimate is $254.57M. The average revenue growth estimate for next year is up 399.50% from the average revenue estimate for this year.
